• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROLLENIUM MEDICAL TECHNOLOGIES, AURORA, ON REVANESSE VERSA+ (WITH LIDOCAINE) 1.2 ML

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROLLENIUM MEDICAL TECHNOLOGIES, AURORA, ON REVANESSE VERSA+ (WITH LIDOCAINE) 1.2 ML Back to Search Results
Model Number PN40083
Device Problems No Apparent Adverse Event (3189); Appropriate Term/Code Not Available (3191)
Patient Problems Scar Tissue (2060); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/20/2023
Event Type  Injury  
Event Description
A patient recounted a narrative that the she was injected with revanesse versa.Her account indicated that she was treated in the marionette lines, nasolabial folds and chin and reported scarring.No clinic medical director narrative was provided.No images were provided.No treatment plan, nor medical history was provided.Prollenium has requested supplemental information on four occasions.Prollenium plans to follow up with supplemental requests for the relevant information with which our investigation can proceed.
 
Manufacturer Narrative
The clinic has not provided us with the requested information.The clinic says they have not written anything down.No information, no treatment, no injection information, etc.Have been recorded by the clinic.The clinic and patient have not provided any images, so far.
 
Event Description
The clinic has provided images of pre- and post-treatment with further information on their company letterhead on (b)(6) 2024.
 
Manufacturer Narrative
Some information provided in this follow up-1 report are additional information; some are correction; the corrections are the adverse event problem codes (section h.6), and manufacturer report number.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REVANESSE VERSA+ (WITH LIDOCAINE) 1.2 ML
Type of Device
REVANESSE VERSA+ (WITH LIDOCAINE)
Manufacturer (Section D)
PROLLENIUM MEDICAL TECHNOLOGIES, AURORA, ON
138 industrial parkway n
aurora, on L4G 4 C3,
CA  L4G 4C3,
Manufacturer (Section G)
PROLLENIUM MEDICAL TECHNOLOGIES INC.
138 industrial parkway n
aurora, on L4G 4 C3
CA   L4G 4C3
Manufacturer Contact
ario khoshbin
138 industrial parkway n
aurora, on L4G 4-C3
CA   L4G 4C3
MDR Report Key18766491
MDR Text Key336062392
Report Number3004423487-2024-00002
Device Sequence Number1
Product Code LMH
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Model NumberPN40083
Device Lot Number23C209
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 01/25/2024
Initial Date FDA Received02/23/2024
Supplement Dates Manufacturer Received01/25/2024
Supplement Dates FDA Received03/05/2024
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age55 YR
Patient SexFemale
Patient RaceWhite
-
-